Cel-Sci Corp (CVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,310 | -13,646 | -7,073 | -26,921 | -20,811 |
| Depreciation Amortization | 2,924 | 1,965 | 995 | 3,969 | 2,978 |
| Accounts payable and accrued liabilities | 2 | 104 | 474 | -461 | -592 |
| Other Working Capital | 1,353 | 796 | 763 | -1,212 | -652 |
| Other Operating Activity | 2,581 | 2,270 | 701 | 5,813 | 5,084 |
| Operating Cash Flow | $-12,449 | $-8,510 | $-4,140 | $-18,811 | $-13,995 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -33 | -33 | -95 | -75 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -13 | -13 |
| Other Investing Activity | 0 | 0 | 0 | -13 | -13 |
| Investing Cash Flow | $-33 | $-33 | $-33 | $-108 | $-88 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 450 | N/A |
| Debt Issued | 350 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,842 | -981 | -482 | -1,773 | -1,315 |
| Common Stock Issued | 12,560 | 7,560 | 5,000 | 23,575 | 12,730 |
| Common Stock Repurchased | N/A | N/A | N/A | 81 | N/A |
| Other Financing Activity | -1,532 | -850 | -469 | -2,821 | -1,093 |
| Financing Cash Flow | $9,537 | $5,729 | $4,049 | $19,512 | $10,322 |
| Beginning Cash Position | 4,738 | 4,738 | 4,738 | 4,146 | 4,146 |
| End Cash Position | 1,793 | 1,924 | 4,614 | 4,738 | 385 |
| Net Cash Flow | $-2,945 | $-2,814 | $-124 | $592 | $-3,761 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,449 | -8,510 | -4,140 | -18,811 | -13,995 |
| Capital Expenditure | -33 | -33 | -33 | -95 | -75 |
| Free Cash Flow | -12,482 | -8,543 | -4,173 | -18,906 | -14,070 |